CV Sciences (CVSI) Finished Goods (2013 - 2026)
CV Sciences' (CVSI) quarterly Finished Goods came in at $1.0 million in Q1 2026, down 28.64% year-on-year from $1.4 million in Q1 2025, and down 8.89% quarter-over-quarter from $1.1 million in Q4 2025.
CV Sciences (CVSI) Finished Goods (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Finished Goods across 13 years of filings, most recently posting $1.0 million for Q1 2026.
- Finished Goods for Q1 2026 came in at $1.0 million, down 28.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 28.64% YoY), and the FY2025 annual result was $1.1 million, down 33.89% from the prior year.
- Finished Goods came in at $1.0 million for Q1 2026 at CV Sciences, down from $1.1 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $2.9 million in Q1 2022 to a low of $1.0 million in Q1 2026.
- The 5-year median for Finished Goods is $1.6 million (2023), against an average of $1.6 million.
- Across the five-year window, Finished Goods tumbled 40.27% in 2022 and climbed 13.41% in 2024, its largest moves.
- CV Sciences' Finished Goods stood at $2.0 million in 2022, then decreased by 20.1% to $1.6 million in 2023, then advanced by 5.37% to $1.7 million in 2024, then plunged by 33.89% to $1.1 million in 2025, then dropped by 8.89% to $1.0 million in 2026.
- The last three Finished Goods figures came in at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Sep 30, 2022 | 2.31 Mn |
| Jun 30, 2022 | 2.12 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Sep 30, 2021 | 2.71 Mn |
| Jun 30, 2021 | 2.89 Mn |